The short version
Brand-name drugs are expensive because they are protected by patents, which means there is no generic competition to drive prices down.
Traditional savings options include insurance formulary coverage, manufacturer copay cards, and patient assistance programs.
Direct-to-patient (DTP) programs are a newer option where manufacturers sell medications directly to you at fixed prices, often 40% to 86% below list price.
If a generic version of your drug exists, it will almost always be cheaper than any brand-name discount program.
DirectRxGuide compares all DTP program prices in one place so you can find the lowest cost for your specific medication.
Why brand-name drugs are so expensive
When a pharmaceutical company develops a new drug, it receives a patent that typically lasts 20 years from the date of filing. During that time, no other company can manufacture or sell a generic version. Without competition, the manufacturer sets the price, and that price is often extremely high.
A single month of a brand-name specialty medication can cost anywhere from $500 to over $10,000 at list price. Even common brand-name drugs for conditions like diabetes, heart disease, and psoriasis regularly carry list prices of $500 to $7,000 per month.
The result is a system where many patients either cannot afford their prescribed medication, skip doses to stretch their supply, or abandon treatment entirely. According to national surveys, roughly 30% of American adults report not taking a medication as prescribed because of cost.
The traditional options for saving on brand-name drugs
Before exploring the newest option, it is worth understanding the savings tools that have been available for years. Each has real benefits, but also real limitations.
Insurance formulary coverage
If your insurance plan covers a brand-name drug on its formulary, you pay a copay or coinsurance rather than the full list price. However, many brand-name drugs require prior authorization, step therapy (trying a cheaper drug first), or sit on the highest copay tier. Even with coverage, your share can be $100 to $300 or more per month.
Manufacturer copay cards
Many manufacturers offer copay assistance cards that reduce your out-of-pocket cost at the pharmacy. These typically work only for patients with commercial insurance, not for those on Medicare or Medicaid. They also do not help uninsured patients, and the savings often expire after a set number of fills or a dollar cap.
Patient assistance programs (PAPs)
Manufacturers also run free or low-cost drug programs for patients who meet income thresholds or lack insurance. These programs can provide medications at no cost, but they require applications, income documentation, and approval. Wait times can be weeks, and not every drug has an active PAP.
Pharmacy shopping
Cash prices for the same brand-name drug can vary significantly from one pharmacy to another. However, when the list price is thousands of dollars, the difference between pharmacies is usually small in comparison. Shopping around helps more for generics than for brand-name medications.
The new option: direct-to-patient programs
Starting in late 2024 and accelerating through 2025 and 2026, pharmaceutical manufacturers have begun selling brand-name medications directly to patients through their own platforms. These are called direct-to-patient (DTP) programs.
Instead of going to a pharmacy and paying whatever price your insurance dictates, you order directly from the manufacturer's website. The medication ships to your door through a contracted mail-order pharmacy at a fixed, transparent price.
The key difference is pricing. Because manufacturers are cutting out intermediaries, they can offer prices significantly below what you would pay at a retail pharmacy. Many DTP programs offer savings of 40% to 86% off the list price.
As of March 2026, DirectRxGuide tracks 12 active DTP platforms from manufacturers including Eli Lilly, Novo Nordisk, Pfizer, AstraZeneca, Amgen, Bristol Myers Squibb, Boehringer Ingelheim, Novartis, GSK, and Johnson & Johnson.
Real examples: how much can you actually save?
These are real DTP program prices available as of March 2026, compared to their list prices.
| Drug | Condition | List Price | DTP Price | Savings |
|---|---|---|---|---|
| Zepbound | Obesity | ~$1,060/mo | $299–$699/mo | Up to 72% off |
| Ozempic | Type 2 diabetes | ~$935/mo | $199–$499/mo | Up to 79% off |
| Sotyktu | Plaque psoriasis | ~$6,868/mo | $950/mo | 86% off |
| Farxiga | Diabetes / heart failure | ~$600/mo | $181.59/mo | 70% off |
| Repatha | High cholesterol | ~$600/mo | $239/mo | ~60% off |
| Wegovy | Obesity | ~$1,350/mo | $199–$349/mo | Up to 85% off |
Prices verified as of March 2026. List prices are approximate wholesale acquisition costs. DTP prices are the published cash-pay prices on each manufacturer's platform. Actual savings depend on dose and fill frequency.
DTP prices vs. retail pharmacy vs. insurance: a side-by-side comparison
To understand where DTP programs fit, it helps to compare all three ways you might pay for a brand-name drug.
| DTP Program | Retail Pharmacy (cash) | Insurance | |
|---|---|---|---|
| Price you pay | Fixed price, 40–86% below list | Full list price or near it | Copay/coinsurance after deductible |
| Price transparency | Published upfront | Often unknown until checkout | Varies by plan and time of year |
| Prior authorization | Not required | Sometimes required by insurance | Often required for brand-name drugs |
| Counts toward deductible | Usually no | Yes, if billed through insurance | Yes |
| Delivery | Mail-order to your door | In-person pickup | In-person or mail-order |
| Best for | Uninsured, underinsured, high-deductible plans | Patients who need medication today | Patients with low copay tiers |
For patients who are uninsured, underinsured, or stuck with a high deductible early in the year, DTP programs are often the cheapest option. For patients with generous insurance that places their drug on a low copay tier, insurance may still be the better deal. The only way to know for sure is to compare your actual out-of-pocket cost across all three options.
How to check if your drug is available through a DTP program
Not every brand-name drug has a DTP program. Here is how to find out if yours does.
- 1
Use the DirectRxGuide Find My Options tool
Enter your condition and insurance status. The tool searches every active DTP program and shows you which ones match your situation, along with pricing.
- 2
Check the manufacturer website directly
If you know who makes your medication, visit their DTP platform. Major platforms include LillyDirect, NovoCare Pharmacy, PfizerForAll, AstraZeneca Direct, AmgenNow, and BMS Patient Connect.
- 3
Ask your doctor or pharmacist
Your prescriber may be aware of DTP options for your medication. Some DTP platforms also accept electronic prescriptions sent directly from your doctor's office.
- 4
Verify eligibility and current pricing
Prices and eligibility can change. Always confirm the current price and any restrictions on the manufacturer's platform before enrolling.
When a generic alternative is the better choice
DTP programs are designed for brand-name drugs that are still under patent. If a generic version of your medication exists, the generic will almost always be cheaper, often by a wide margin.
Generic drugs contain the same active ingredient, at the same dose, in the same dosage form as the brand-name version. The FDA requires generics to meet the same standards for quality, safety, and effectiveness. The difference is price: generics typically cost 80% to 95% less than their brand-name equivalents.
Before exploring a DTP program, ask your doctor or pharmacist whether a generic version of your medication is available. If one exists, it is almost certainly your cheapest option.
However, many of the most expensive medications in the United States, including newer treatments for obesity, diabetes, psoriasis, and heart disease, do not yet have generic alternatives. For these drugs, DTP programs may offer the most significant savings available.
How DirectRxGuide compares all your options in one place
With 12 DTP platforms and dozens of drugs, comparing prices across manufacturers is time-consuming. Each platform has its own website, its own eligibility rules, and its own pricing structure.
DirectRxGuide is an independent aggregator that tracks every active DTP program in the United States. No pharmaceutical manufacturer funds, sponsors, or influences this platform. The goal is simple: give patients and providers one place to compare all available options.
The Find My Options tool lets you search by condition and insurance status. It returns every matching DTP program, ranked by out-of-pocket cost, so you can see at a glance which option saves you the most money. No account is required, and no personal data is stored.
Find the lowest price for your medication
Use our free tool to see which DTP programs match your condition and insurance status. No account required and no personal data stored.
Find My OptionsMedical disclaimer: DirectRxGuide does not provide medical advice. All content is for informational purposes only. Always consult your healthcare provider before making changes to your medications. DirectRxGuide is not a pharmacy, prescriber, or healthcare provider. Program eligibility, pricing, and availability are subject to change. Verify current details directly with the manufacturer before enrolling.